Literature DB >> 2200624

Intragenic deletions in 164 boys with Duchenne muscular dystrophy (DMD) studied with dystrophin cDNA.

M Upadhyaya1, R A Smith, N S Thomas, A M Norman, P S Harper.   

Abstract

DNA from 164 unrelated Duchenne muscular dystrophy patients was screened with cDNA probes from the dystrophin gene. Molecular deletions were demonstrated in 82 (50%) subjects. Sixty-two deletions (76%) were detected using cDNA probes Cf56a (cDNA 8) and Cf56b (cDNA 6-7) which map to the centre of the gene, while 22 deletions (27%) mapped to the 5' end of the gene. In three subjects, the deletion extended from the 5' end to the centre of the gene. One deletion was identified by probe 47-4 (cDNA 5b-7) alone. In six of the deletions, junction fragments of altered size were observed. Using the three cDNA probes, RW2kb, Cf56a (cDNA 8) and Cf56b (cDNA 6-7), 99% of the deletions were detected. This will have implications for prenatal diagnosis in deletion families. Unlike Becker muscular dystrophy, where the deletions are more homogeneous, the deletions in the present study were heterogeneous both in size and position. No correlation between intelligence and either site or extent of deletion was found.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200624     DOI: 10.1111/j.1399-0004.1990.tb03530.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Quantitative Southern blot analysis in the dystrophin gene of Japanese patients with Duchenne or Becker muscular dystrophy: a high frequency of duplications.

Authors:  Y Hiraishi; S Kato; T Ishihara; T Takano
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

2.  Patterns of deletions of the dystrophin gene in different European populations.

Authors:  G A Danieli; F Mioni; C R Müller; L Vitiello; M L Mostacciuolo; T Grimm
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

3.  Experience with screening newborns for Duchenne muscular dystrophy in Wales.

Authors:  D M Bradley; E P Parsons; A J Clarke
Journal:  BMJ       Date:  1993-02-06

4.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

5.  Topographic pattern of the rearrangement of the dystrophin gene in Japanese Duchenne muscular dystrophy.

Authors:  N Imoto; T Arinami; K Hamano; K Matsumura; H Yamada; H Hamaguchi; H Takita
Journal:  Hum Genet       Date:  1993-12       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.